Navigation Links
CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
Date:8/27/2007

blation System, is designed to treat cardiac arrhythmias through the use of cryoenergy, or extreme cold, to destroy targeted cardiac tissue. The Cryoablation System has been approved in Europe for the treatment of atrial fibrillation, and atrial flutter, the two most common and difficult to treat arrhythmias, since 2002. In the United States, CryoCor is conducting a pivotal trial to evaluate the safety and efficacy of the Cryoablation System for the treatment of atrial fibrillation and the Cryoablation System has been approved for the treatment of right atrial flutter. For more information please visit the Company's website at http://www.cryocor.com

Forward Looking Statements

The statements in this press release that are not descriptions of historical facts are forward-looking statements that are subject to risks and uncertainties. These include statements related to the Company's lead time over other companies conducting atrial fibrillation ablation pivotal trials, ability of obtain FDA approval for and commercialize its product for the treatment of atrial fibrillation and its timing for doing so, including its timing for the filing the related PMA, and ability to, and the benefits from, placing its systems in high volume ablation centers in the U.S., all of which are prospective. Such statements are only predictions and reflect CryoCor's expectations and assumptions as of the date of this press release based on currently available operating, financial, and competitive information. The actual events or results may differ materially from those projected in such forward-looking statements due to a number of factors, including risks involved with CryoCor's ability to obtain regulatory approval in the United States for its cryoablation system for use in treating atrial fibrillation within its anticipated timeframes, if at all; risks associated with the Company's ability to submit a PMA for atrial fibrillati
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Celsion Completes Enrollment in Phase I Liver Cancer Study
3. LANI completes Phase I in Japan and to commence Phase I in UK
4. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 Actavis plc (NYSE: ... offering of $21 billion aggregate principal amount of senior ... offering to be issued by its indirect wholly-owned subsidiary, ... other subsidiaries (the "Notes"), as follows: Logo ... Notes* , $500,000,000 , Due 2016 , ...
(Date:3/3/2015)... 2015  Cumberland Pharmaceuticals Inc. (NASDAQ: ... hospital acute care and gastroenterology, today announced achievement ... include top-line results from the Company,s Hepatoren Phase ... Application (sNDA) with pediatric data for Caldolor and ... II clinical trial. "The sNDA for ...
(Date:3/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tbjpmj/blister_packaging ) ... Market in the US 2015-2019" report to their ... the US to grow at a CAGR of 6.11% ... form of high-visibility packaging that uses pre-formed plastic packs ... a base layer, made either of plastic or aluminum, ...
Breaking Medicine Technology:Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 2Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 3Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 4Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 5Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 6Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 7Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 8Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 9Actavis Announces Pricing of Public Offering of Senior Notes in Connection with Pending Acquisition of Allergan 10Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 2Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 3Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 4Cumberland Pharmaceuticals Reports Clinical And Regulatory Milestones 5United States Blister Packaging Market 2015-2019 - Growing Demand in Pharmaceuticals Industry with Amcor, Bemis, MeadWestvaco & Sonoco Products Dominating 2
... Oct. 31, 2011 Rock Creek Pharmaceuticals, a wholly owned ... today announced the second presentation of research findings related to ... a Tobacco Alkaloid, Ameliorates Disease in a Mouse Model of ... meeting of the American Thyroid Association in Indian Wells, CA ...
... SYDNEY, Oct. 31, 2011  To successfully irradiate a moving lung ... the tumor from moving or a means to compensate for ... Hospital Cancer Centre (Randwick, New South Wales) chose the second ... for the first time to treat a 75-year-old male patient ...
Cached Medicine Technology:Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 2Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 3Rock Creek Pharmaceuticals Announces Completion of Medical Conferences on Anatabloc™ Research, Comments on Research Presentation at American Thyroid Association Annual Meeting 4Australia's Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elekta's Advanced 4D Motion Management Technology 2Australia's Prince of Wales Hospital Launches New Era of Targeted Lung Cancer Treatments with Elekta's Advanced 4D Motion Management Technology 3
(Date:3/4/2015)... MILWAUKEE, WI (PRWEB) March 04, 2015 ... dental products distributor announced on Wednesday its strategic partnership ... customers with online tools that will introduce them to ... trends happening in dentistry. , The Dental Exchange ... platform exclusively for the dental industry. Unlike other social ...
(Date:3/4/2015)... Georgia (PRWEB) March 04, 2015 The ... Sleep Awareness Week with World Sleep Awareness Day being ... awareness to the health and financial risks associated with ... support, the Sleep Apnea Treatment Centers of America have ... daily educational articles, they hope will virally inspire conversation ...
(Date:3/4/2015)... A new poll by The ... —“What retirement cost is hardest for you to cover?” ... costs were most difficult, 40% — as those who ... percent said nourishing food, and 4% said transportation, was ... because it illustrates the significance of healthcare costs on ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... a worrisome public health issue worldwide. The rising prevalence ... economic and social burden in both developed and developing ... is projected to rise to 1.5 billion, equating to ... of these patients are forecast to come from the ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 Theme and ... a new title pack for Final Cut Pro X entitled ... animated text presets to any FCPX editors project.” Said Christiana ... the tools needed to add animated font to their FCPX ... drawn text look all within Final Cut Pro X. ProFont ...
Breaking Medicine News(10 mins):Health News:Ada Products Company, Inc. Announces Strategic Partnership with the Dental Exchange 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 2Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 3Health News:Innovative Sleep Apnea Procedure Could Save US Healthcare System Billions 4Health News:Most Difficult Cost In Retirement? Retirees Evenly Split Between Housing and Healthcare, Says New Poll By The Senior Citizens League 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 2Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 3Health News:Aging Population Drives Demand for Blood Pressure Monitoring & Measurement Instruments, According to a New Report by Global Industry Analysts, Inc. 4Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2
... in the brain of patients suffering from mild cognitive ... MCI to Alzheimer’s disease (AD) dementia//, according to a ... Aging. ,Researchers at Mount Sinai School of ... may be delayed by eliminating plaque causing beta-amyloid peptides ...
... Pasteur, the world's third-largest pharmaceutical firm together with the Public ... trials on an avian flu vaccine, which could be used ... Chotpitayasunondh, a member of the ministry's human avian flu study ... children aged six months to 18 years owing to the ...
... experts have warned that the increasing rate of tuberculosis, ... was controlled among the socially excluded groups. // ... higher among the ,homeless population, drug abusers, HIV patients ... and economic situation in England. ,Unless ...
... take acetaminophen for their aches and pains could be ... the findings of a new study// . ... recommended daily dose of acetaminophen showed abnormalities in blood ... initially they had come across liver damage in patients ...
... dose of radiotherapy may be beneficial in early stage of ... cancer// from progressing to a deadlier form, they reported in ... (DCIS) occurs in the duct cells lining the milk ducts. ... to the ducts and has not spread outside. The usual ...
... taken over as president of the British Medical Association ... quoted from poet laureate Rabindranath Tagore's "Gitanjali", "Where the ... over office. ,Kumar, who was born ... London and the Homerton Hospitals and has a distinguished ...
Cached Medicine News:Health News:Discovery of Elevated Amyloid Peptide levels could lead to Alzheimer’s Preventio 2Health News:Agreement for Joint Trials of Avian Flu Vac cine on Humans 2Health News:Socio-economically Excluded People, more affected by Tuberculosis , 2Health News:Even Normal Doses Of Tylenol Could Damage Liver 2Health News:Indian Origin Woman is the New Head of British Medical Association 2
Inquire...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
Medicine Products: